Alliance Pharma plc (AIM: APH)
London
· Delayed Price · Currency is GBP · Price in GBX45.75
+0.80 (1.78%)
Dec 31, 2024, 12:39 PM GMT+1
Alliance Pharma Revenue
Alliance Pharma had revenue of 83.87M GBP in the half year ending June 30, 2024, with 6.47% growth. This brings the company's revenue in the last twelve months to 183.15M, up 7.70% year-over-year. In the year 2023, Alliance Pharma had annual revenue of 180.68M with 7.92% growth.
Revenue (ttm)
183.15M
Revenue Growth
+7.70%
P/S Ratio
1.35
Revenue / Employee
631.54K
Employees
292
Market Cap
247.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 180.68M | 13.26M | 7.92% |
| Dec 31, 2022 | 167.42M | 4.21M | 2.58% |
| Dec 31, 2021 | 163.21M | 33.41M | 25.74% |
| Dec 31, 2020 | 129.80M | -5.84M | -4.30% |
| Dec 31, 2019 | 135.64M | 17.43M | 14.74% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Indivior | 881.89M |
Alliance Pharma News
- 3 months ago - Alliance Pharma PLC (FRA:DVL) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue ... - GuruFocus
- 3 months ago - Half Year 2024 Alliance Pharma PLC Earnings Call Transcript - GuruFocus